Literature DB >> 26066885

Recessive Dystrophic Epidermolysis Bullosa: Advances in the Laboratory Leading to New Therapies.

David T Woodley1, Mei Chen2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26066885     DOI： 10.1038/jid.2015.149

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  16 in total

1.  Aminoglycosides restore full-length type VII collagen by overcoming premature termination codons: therapeutic implications for dystrophic epidermolysis bullosa.

Authors:  Jon Cogan; Jacqueline Weinstein; Xinyi Wang; Yingping Hou; Sabrina Martin; Andrew P South; David T Woodley; Mei Chen
Journal:  Mol Ther       Date:  2014-07-23       Impact factor: 11.454

2.  Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing.

Authors:  David T Woodley; Jennifer Remington; Yi Huang; Yingping Hou; Wei Li; Douglas R Keene; Mei Chen
Journal:  Mol Ther       Date:  2007-01-23       Impact factor: 11.454

3.  Bone marrow transplantation for recessive dystrophic epidermolysis bullosa.

Authors:  John E Wagner; Akemi Ishida-Yamamoto; John A McGrath; Maria Hordinsky; Douglas R Keene; David T Woodley; Mei Chen; Megan J Riddle; Mark J Osborn; Troy Lund; Michelle Dolan; Bruce R Blazar; Jakub Tolar
Journal:  N Engl J Med       Date:  2010-08-12       Impact factor: 91.245

4.  A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa.

Authors:  Supriya S Venugopal; Wenfei Yan; John W Frew; Heather I Cohn; Lesley M Rhodes; Kim Tran; Wei Melbourne; Janis A Nelson; Marian Sturm; Janice Fogarty; M Peter Marinkovich; Satomi Igawa; Akemi Ishida-Yamamoto; Dedee F Murrell
Journal:  J Am Acad Dermatol       Date:  2013-09-24       Impact factor: 11.527

5.  Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.

Authors:  Mei Chen; Noriyuki Kasahara; Douglas R Keene; Lawrence Chan; Warren K Hoeffler; Deborah Finlay; Maria Barcova; Paula M Cannon; Constance Mazurek; David T Woodley
Journal:  Nat Genet       Date:  2002-11-11       Impact factor: 38.330

6.  Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa.

Authors:  Tracy Wong; Luke Gammon; Lu Liu; Jemima E Mellerio; Patricia J C Dopping-Hepenstal; John Pacy; George Elia; Rosemary Jeffery; Irene M Leigh; Harshad Navsaria; John A McGrath
Journal:  J Invest Dermatol       Date:  2008-04-03       Impact factor: 8.551

7.  Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa.

Authors:  David T Woodley; Douglas R Keene; Tom Atha; Yi Huang; Kathi Lipman; Wei Li; Mei Chen
Journal:  Nat Med       Date:  2004-06-13       Impact factor: 53.440

8.  Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone.

Authors:  David T Woodley; Gerald G Krueger; Cynthia M Jorgensen; Janet A Fairley; Tom Atha; Yi Huang; Lawrence Chan; Douglas R Keene; Mei Chen
Journal:  J Invest Dermatol       Date:  2003-11       Impact factor: 8.551

9.  Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa.

Authors:  David T Woodley; Xinyi Wang; Mahsa Amir; Brian Hwang; Jennifer Remington; Yingpin Hou; Jouni Uitto; Douglas Keene; Mei Chen
Journal:  J Invest Dermatol       Date:  2013-01-15       Impact factor: 8.551

10.  De novo anti-type VII collagen antibodies in patients with recessive dystrophic epidermolysis bullosa.

Authors:  David T Woodley; Jon Cogan; Xinyi Wang; Yingping Hou; Cyrus Haghighian; Gail Kudo; Douglas R Keene; Mei Chen
Journal:  J Invest Dermatol       Date:  2013-11-08       Impact factor: 8.551
View more
  3 in total

Review 1.  Minor collagens of the skin with not so minor functions.

Authors:  Georgios Theocharidis; John T Connelly
Journal:  J Anat       Date:  2017-02-02       Impact factor: 2.610

2.  Toward treatment and cure of epidermolysis bullosa.

Authors:  Jouni Uitto
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-11       Impact factor: 11.205

3.  Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome.

Authors:  Oliver Gross; Clifford E Kashtan; Michelle N Rheault; Frances Flinter; Judith Savige; Jeffrey H Miner; Roser Torra; Elisabet Ars; Constantinos Deltas; Isavella Savva; Laura Perin; Alessandra Renieri; Francesca Ariani; Francesca Mari; Colin Baigent; Parminder Judge; Bertrand Knebelman; Laurence Heidet; Sharon Lagas; Dave Blatt; Jie Ding; Yanqin Zhang; Daniel P Gale; Marco Prunotto; Yong Xue; Asher D Schachter; Lori C G Morton; Jacqui Blem; Michael Huang; Shiguang Liu; Sebastien Vallee; Daniel Renault; Julia Schifter; Jules Skelding; Susie Gear; Tim Friede; A Neil Turner; Rachel Lennon
Journal:  Nephrol Dial Transplant       Date:  2017-06-01       Impact factor: 5.992
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.